SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-052001
Filing Date
2021-08-17
Accepted
2021-08-17 18:03:57
Documents
2
Period of Report
2021-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1592
2 EX-24 DOCUMENT attachment1.htm EX-24 2153
  Complete submission text file 0001209191-21-052001.txt   5322
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR BOCA RATON FL 33487
Business Address
Barlow Jane F (Reporting) CIK: 0001736026 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 211184392